Tardive dyskinesia (TD) is an involuntary movement disorder — causing uncontrollable, repetitive movements of the face, torso, and limbs — that can develop as a side effect of long-term use of certain psychiatric and gastrointestinal medications. An estimated 600,000 Americans are affected, and roughly 65 percent haven't been diagnosed. This resolution supports designating May 4–10, 2025, as Tardive Dyskinesia Awareness Week and encourages both the public and the medical community to learn more about the condition, since the FDA has approved treatments that can make a real difference for people living with it.
Congressional Summary
This resolution supports the designation of Tardive Dyskinesia Awareness Week. Tardive dyskinesia is a movement disorder characterized by involuntary and uncontrolled movements of muscles in the face, torso, and extremities.
Details
- Congress
- 119th
- Chamber
- House
- Status
- summarized
- Action
- Introduced in House
- Action Date
- 2025-05-07
- Date Added
- 2026-04-09